HOME › DRUGS › TANEZUMAB
ACTIVE SUBSTANCE / INN

TANEZUMAB

Brand name(s): Raylumis
EMA LISTED
REFUSED
Osteoarthritis;Pain
ACTIVE SUBSTANCE
Tanezumab
REGULATORS
EMA
SPONSORS / MAH
Pfizer Europe MA EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RaylumisPfizer Europe MA EEIGRefusedOsteoarthritis;Pain

FULL INTELLIGENCE ON TANEZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →